XPO1 and influenza: Indeed, inhibitors of exportin-1, such as those developed by Karyopharm® Therapeutics [50], that inhibit nuclear export of all cargoes recognized by exportin-1 bearing a NES can be efficacious broad-spectrum antivirals (e.g., against RSV and influenza infection).